Affimed NV Performance
| AFMDDelisted Stock | USD 0.18 0.04 18.18% |
The firm shows a Beta (market volatility) of 6.33, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Affimed NV will likely underperform. Affimed NV right now shows a risk of 0.0%. Please confirm Affimed NV treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to decide if Affimed NV will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Affimed NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Affimed NV is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Affimed |
Affimed NV Relative Risk vs. Return Landscape
If you would invest 18.00 in Affimed NV on October 8, 2025 and sell it today you would earn a total of 0.00 from holding Affimed NV or generate 0.0% return on investment over 90 days. Affimed NV is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Affimed, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Affimed NV Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Affimed NV's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Affimed NV, and traders can use it to determine the average amount a Affimed NV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AFMD |
Based on monthly moving average Affimed NV is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Affimed NV by adding Affimed NV to a well-diversified portfolio.
Affimed NV Fundamentals Growth
Affimed Stock prices reflect investors' perceptions of the future prospects and financial health of Affimed NV, and Affimed NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Affimed Stock performance.
| Return On Equity | -1.49 | |||
| Return On Asset | -0.49 | |||
| Operating Margin | (87.09) % | |||
| Current Valuation | (12.67 M) | |||
| Shares Outstanding | 16.39 M | |||
| Price To Earning | (2.04) X | |||
| Price To Book | 0.06 X | |||
| Price To Sales | 0.53 X | |||
| Revenue | 8.28 M | |||
| EBITDA | (102.38 M) | |||
| Cash And Equivalents | 237.23 M | |||
| Cash Per Share | 1.59 X | |||
| Total Debt | 19.35 M | |||
| Debt To Equity | 0.1 % | |||
| Book Value Per Share | 1.05 X | |||
| Cash Flow From Operations | (110.27 M) | |||
| Earnings Per Share | (5.09) X | |||
| Total Asset | 97.16 M | |||
| Retained Earnings | (536.13 M) | |||
| Current Asset | 78.33 M | |||
| Current Liabilities | 8.94 M | |||
About Affimed NV Performance
By analyzing Affimed NV's fundamental ratios, stakeholders can gain valuable insights into Affimed NV's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Affimed NV has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Affimed NV has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany. Affimed NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 197 people.Things to note about Affimed NV performance evaluation
Checking the ongoing alerts about Affimed NV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Affimed NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Affimed NV is not yet fully synchronised with the market data | |
| Affimed NV has some characteristics of a very speculative penny stock | |
| Affimed NV has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.28 M. Net Loss for the year was (105.94 M) with profit before overhead, payroll, taxes, and interest of 5.64 M. | |
| Affimed NV currently holds about 237.23 M in cash with (110.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Affimed NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Affimed NV's stock is overvalued or undervalued compared to its peers.
- Examining Affimed NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Affimed NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Affimed NV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Affimed NV's stock. These opinions can provide insight into Affimed NV's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Affimed Stock
If you are still planning to invest in Affimed NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Affimed NV's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |